Home › Compare › RPGHF vs ABBV
RPGHF yields 118.34% · ABBV yields 3.06%● Live data
📍 RPGHF pulled ahead of the other in Year 1
Combined, RPGHF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RPGHF + ABBV for your $10,000?
RPMGlobal Holdings Limited develops and provides mining software solutions in Australia, Asia, the Americas, Africa, and Europe. It operates through Software and Advisory divisions. The company provides software licensing, consulting, implementation, and support services; and technical, advisory, and training services. It also offers enterprise planning framework; Open Cut Phosphate, Open Pit Metals, Open Pit Diamond, Quarry, and Steep coal solutions; RESERVER, a mine reserve model; EmissionsManager, a SaaS based solution for collecting, calculating, monitoring, and reporting emissions data; XECUTE that enables planners to build a term schedule; Asset Management; XPAC solution, a scheduling software; XACT, a short-term mining operation solution, as well as Enterprise Optimiser; IMAFS, which uses AI to enhance inventory management; and Schedule Optimisation Tool for scenario planning and comparisons. In addition, the company provides Attain, a flexible mine schedule optimization tool; Strategic Design Optimiser; Stratigraphic metal solution; underground metals solution; underground coal solution; underground potash solution; product optimizer; HAULSIM, a 3-D discrete event simulation software; SIMULATE, an event simulation software for original equipment manufacturers; TALPAC-3D, a truck and loader productivity calculator; TALPAC, a truck and loader productivity solution for underground coal mines; Open Cut Coal solution; and DRAGSIM, a dragline simulation software. Further, it offers XERAS Enterprise, a budgeting solution; XERAS, a financial modelling solution; ShiftManager, a mine engineering and shift management software; MINVU, a mining management software; and AMT, an asset maintenance software for contractors and OEMs, as well as AMT4SAP. The company was formerly known as RungePincockMinarco Limited and changed its name to RPMGlobal Holdings Limited in March 2017. RPMGlobal Holdings Limited was founded in 1968 and is headquartered in Brisbane, Australia.
Full RPGHF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.